Automated Chemotherapy Preparation And Infusion Market Report 2026

Automated Chemotherapy Preparation And Infusion Market Report 2026 Market Overview

• Automated Chemotherapy Preparation And Infusion Market Report 2026 market size has reached to $1.37 billion in 2025 • Expected to grow to $2.04 billion in 2030 at a compound annual growth rate (CAGR) of 8.3% • Growth Driver: Surge In Increasing Cancer Incidence Fueling The Growth Of The Market Due To Rising Global Cancer Burden And Growing Demand For Safe Chemotherapy Administration • Market Trend: Advancements In Robotic Compounding Technology Enhancing Chemotherapy Safety And Precision • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Automated Chemotherapy Preparation And Infusion Market?

Automated chemotherapy preparation and infusion refers to the integrated robotic hardware and closed-system transfer software platforms used within oncology pharmacies to precisely compound and safely deliver cytotoxic cancer medications. By automating the liquid handling, dilution, and labeling steps within a sterile enclosure, these systems eliminate pre-analytical dosing errors, optimize inventory tracking, and protect pharmacy staff from direct exposure to hazardous chemical compounds. The main product types of automated chemotherapy preparation and infusion include automated chemotherapy compounding systems, smart infusion pumps, integrated preparation and infusion systems, and workflow management software. Automated chemotherapy compounding systems refer to robotic and automated platforms that accurately prepare cytotoxic medications while improving dosing precision, workflow efficiency, and healthcare worker safety. These solutions support chemotherapy preparation and chemotherapy infusion modalities and utilize technologies such as fully automated robotic systems, semi automated workstations, and artificial intelligence enabled workflow automation. They are used with cytotoxic drug classes including alkylating agents, antimetabolites, plant alkaloids, and antitumor antibiotics and are utilized by end users including oncology clinics and centers, hospitals, specialty pharmacies, and others.

What Is The Automated Chemotherapy Preparation And Infusion Market Growth Forecast?

The automated chemotherapy preparation and infusion market size is expected to see strong growth in the next few years. It will grow to $2.04 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing demand for precision oncology workflows, growing investment in automated pharmacy infrastructure, rising adoption of personalized chemotherapy treatment, expanding outpatient cancer treatment services, increasing focus on medication traceability and regulatory compliance. Major trends in the forecast period include increasing adoption of robotic chemotherapy compounding systems, growing demand for closed system drug preparation solutions, rising focus on reducing chemotherapy medication errors, expanding implementation of sterile automated pharmacy workflows, increasing emphasis on occupational safety in oncology pharmacies.

What Is The Driver Of The Automated Chemotherapy Preparation And Infusion Market?

The increasing cancer incidence is expected to propel the growth of the automated chemotherapy preparation and infusion market going forward. Cancer refers to a group of diseases characterized by the uncontrolled growth and spread of abnormal cells within the body. Increasing cancer incidence is on the rise due to the aging global population, as advancing age leads to the accumulation of genetic mutations and prolonged exposure to cancer risk factors, resulting in a higher prevalence of cancer. Automated chemotherapy preparation and infusion systems enable safer and more efficient cancer care by automating drug preparation and delivery, reducing errors, minimizing hazardous drug exposure, and improving oncology workflow efficiency. For instance, in July 2026, according to the World Health Organization (WHO), a Switzerland-based health agency, annual new cancer cases reached an estimated 20.6 million globally, with close to 10 million deaths, and this figure is projected to rise to nearly 35 million cases by 2050. Therefore, the increasing cancer incidence is driving the growth of the automated chemotherapy preparation and infusion industry.

Key Players In The Global Automated Chemotherapy Preparation And Infusion Market

Major companies operating in the automated chemotherapy preparation and infusion market report are Becton Dickinson and Company, Baxter International Inc., Fresenius Kabi AG, B. Braun Melsungen AG, ICU Medical Inc., Grifols S.A., Terumo Corporation, Omnicell Inc., Moog Inc., Nipro Corporation, Equashield LLC, Loccioni Group S.r.l., ARxIUM Inc., CODAN Medizinische Geräte GmbH, Micrel Medical Devices S.A., Yuyama Co. Ltd., Simplivia Healthcare Ltd., ACE Medical Co. Ltd., Comecer S.p.A., Fagron NV

Global Automated Chemotherapy Preparation And Infusion Market Trends and Insights

Major companies operating in the automated chemotherapy preparation and infusion market are focusing on developing advanced robotic compounding systems to improve medication accuracy, enhance workflow efficiency, and reduce healthcare workers' exposure to hazardous drugs. Robotic chemotherapy compounding systems are automated solutions that prepare chemotherapy drugs with high precision and consistency. They improve dosing accuracy, enhance workflow efficiency, and reduce healthcare workers' exposure to hazardous drugs. For instance, in June 2026, Korea University Ansan Hospital, a South Korea-based healthcare organization, introduced the APOTECA Chemo robotic chemotherapy compounding system in its Department of Pharmacy. The system automates the preparation of chemotherapy medications based on individual patient prescriptions, standardizes the compounding process across treatment cycles, and minimizes healthcare workers' exposure to hazardous drugs, supporting the adoption of automated chemotherapy preparation technologies.

What Are Latest Mergers And Acquisitions In The Automated Chemotherapy Preparation And Infusion Market?

In June 2024, Equashield, a US-based developer of the EQUASHIELD Pro automated chemotherapy compounding robot, partnered with Pharmacy Stars to enhance safety and regulatory compliance in healthcare. The collaboration integrated automated hazardous drug compounding robotics with digital compliance software to streamline chemotherapy preparation workflows. As a result, it enhanced real-time traceability, safety verification, and documentation, improving the accuracy and regulatory compliance of automated oncology compounding. Pharmacy Stars is a US-based provider of enterprise pharmacy regulatory compliance and quality management software.

What Defines the Automated Chemotherapy Preparation And Infusion Market?

The automated chemotherapy preparation and infusion market includes revenues earned by entities by providing services such as robotic chemotherapy compounding, automated dose verification, infusion therapy management, equipment maintenance, and software integration. The market value includes the value of related goods sold by the service provider or included within the service offering. The automated chemotherapy preparation and infusion market also includes sales of automated chemotherapy compounding systems, robotic chemotherapy preparation systems, automated drug compounding robots, closed-system transfer devices (CSTDs) and automated infusion pumps. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Automated Chemotherapy Preparation And Infusion Market Report 2026?

The automated chemotherapy preparation and infusion market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the automated chemotherapy preparation and infusion industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.